The role of nuclear medicine in monitoring treatment in skeletal malignancy.
about
A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the boneMetabolic flare phenomenon on 18 fluoride-fluorodeoxy glucose positron emission tomography-computed tomography scans in a patient with bilateral breast cancer treated with second-line chemotherapy and bevacizumab.MIBG molecular imaging for evaluating response to chemotherapy in patients with malignant pheochromocytoma: preliminary results.Positron emission tomography imaging as a cancer biomarker.Orthopaedic perspective on bone metastasis.The EANM practice guidelines for bone scintigraphyBone tumor imaging, then and now: review article.Use of NaF-18-Positron Emission Tomography/Computed Tomography in the Detection of Bone Metastasis from Papillary Renal Cell Carcinoma.Treatment response evaluation with 18F-FDG PET/CT and 18F-NaF PET/CT in multiple myeloma patients undergoing high-dose chemotherapy and autologous stem cell transplantation.[68Ga]PSMA-HBED-CC Uptake in Osteolytic, Osteoblastic, and Bone Marrow Metastases of Prostate Cancer Patients.
P2860
Q31140219-6742742D-6D5A-420F-8A89-AEB117ABE56EQ35233066-8F7584EC-622E-4F29-A4D6-0613D8C1E393Q36776978-CF459D7D-DBDF-4F69-8CAD-EDA17FED9FF2Q36950458-6A684F6F-A0F0-4765-8F7A-B89B7D8FC31AQ37029207-114BB8A5-0922-4E99-8A06-34DF7317FF76Q37063185-FE70F661-8DCE-48F7-ACAD-1163AE633A76Q38255167-CBAAAAFF-EF2F-4E60-ABC0-BCCE3D8E9D30Q42261284-A1B44348-0404-422A-A0DA-5146B0B2B5B7Q48089815-E10D5EB7-050A-47DC-9DFA-0DE78A93A8CDQ48127957-BE65C612-40C6-4082-9364-3326E73FD55E
P2860
The role of nuclear medicine in monitoring treatment in skeletal malignancy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The role of nuclear medicine in monitoring treatment in skeletal malignancy.
@ast
The role of nuclear medicine in monitoring treatment in skeletal malignancy.
@en
The role of nuclear medicine in monitoring treatment in skeletal malignancy.
@nl
type
label
The role of nuclear medicine in monitoring treatment in skeletal malignancy.
@ast
The role of nuclear medicine in monitoring treatment in skeletal malignancy.
@en
The role of nuclear medicine in monitoring treatment in skeletal malignancy.
@nl
prefLabel
The role of nuclear medicine in monitoring treatment in skeletal malignancy.
@ast
The role of nuclear medicine in monitoring treatment in skeletal malignancy.
@en
The role of nuclear medicine in monitoring treatment in skeletal malignancy.
@nl
P356
P1476
The role of nuclear medicine in monitoring treatment in skeletal malignancy
@en
P2093
I Fogelman
P304
P356
10.1053/SNUC.2001.23527
P50
P577
2001-07-01T00:00:00Z